Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva

Journal of Glaucoma

Volumn 10, Issue 3, 2001, Pages 237-249

  Broadway, David C ^a,b   Chang, Lydia P ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b WEST NORWICH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIFIBROTIC AGENT; ANTIGLAUCOMA AGENT; ANTIMETABOLITE; ANTIOXIDANT; BASIC FIBROBLAST GROWTH FACTOR; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPIVEFRINE; FLUOROMETHOLONE; FLUOROURACIL; MITOMYCIN C; PLATELET DERIVED GROWTH FACTOR; STEROID; TIMOLOL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; CLINICAL TRIAL; ETHNIC GROUP; FILTERING OPERATION; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; NEGRO; NONHUMAN; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RAT; REVIEW; RISK FACTOR; TRABECULECTOMY; TREATMENT FAILURE; UVEITIS; WOUND HEALING;

EID: 0034978876     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200106000-00017     Document Type: Review

References (166)

1. Wound healing in glaucoma filtering surgery
2. Clinico-pathologic correlation in eyes with failed fistulizing surgery
3. Five-year follow-up of the Fluorouracil Filtering Surgery Study
4. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C
5. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery
6. A major review of antimetabolites in glaucoma therapy
7. Trabecular surgery
8. Trabeculectomy: A follow-up study
9. Trabeculectomy: A retrospective long-term follow-up of 444 cases
10. Long-term results of trabeculectomy in the Japanese: An analysis by life-table method
11. A critical analysis of the trabeculectomy results by a prospective follow-up design
12. Trabeculectomy: A prospective study of complications and results of long-term follow-up
13. Medically uncontrolled glaucoma in the aphakic eye
14. Surgical management of chronic glaucoma in aphakia
15. Trabeculectomy in aphakic eyes
16. Surgical therapy of chronic glaucoma in aphakia and pseudophakia
17. Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgery
18. Filtration surgery in the treatment of neovascular glaucoma
19. Surgical management of the secondary glaucomas
20. Surgical control of glaucoma in the negro
21. Filtering procedures in American blacks
22. Trabeculectomy in black patients
23. Filtration surgery in black patients: Early results in a West Indian population
24. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis
25. Racial differences in the results of glaucoma filtration surgery: Are racial differences in the conjunctival cell profile important?
26. The influence of prior therapy on the success of trabeculectomy
27. Glaucoma triple procedures: Efficacy of intraocular pressure control and visual outcome
28. Trabeculectomy combined with beta-irradiation for congenital glaucoma
29. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery
30. Trabeculectomy in young patients
31. Young patient trabeculectomy. Assessment of risk factors for failure
32. The place of trabeculectomy in the treatment of glaucoma
33. New model of conjunctival scarring in the mouse eye
34. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro
35. Promotion of wound repair in old mice by local injection of macrophages
36. Growth factors and wound healing: Biochemical properties of growth factors and their receptors
37. Growth factors and ocular wound healing
38. The role of growth factors in wound healing
39. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
40. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
41. Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: A selective effect on Bcl-XL expression
42. Interferon-beta mediates stromal cell rescue of T cells from apoptosis
43. The effect of total vitrectomy on filtration surgery in the aphakic eye
44. Chemotactic activity of aqueous humor: A cause of failure of trabeculectomies?
45. The inhibitory effect of aqueous humor on the growth of cells in tissue cultures
46. The effect of aqueous humor on the growth of subconjunctival fibroblasts in tissue culture and its implications for glaucoma surgery
47. Aqueous humor changes after experimental filtering surgery
48. Effects of human glaucomatous and non-glaucomatous aqueous humor on fibroblast proliferation in vitro
49. Secondary glaucoma in aphakia
50. Aphakic glaucoma: Prophylaxis and management
51. Pseudophakic glaucoma
52. Use of antifibrosis agents and glaucoma drainage devices in the American and Japanese Glaucoma Societies
53. Mitomycin C as adjunctive therapy with glaucoma implant surgery
54. Glaucoma drainage devices: Pros and cons
55. 'Cyclodiode.' Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma
56. Post-traumatic angle recession glaucoma: A risk factor for bleb failure after trabeculectomy
57. Surgical management of post-traumatic angle recession glaucoma
58. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis
59. Trabeculectomy in uveitis: Are antimetabolites necessary at the first procedure?
60. Surgical management of the inflammatory glaucomas
61. Systemic uveitis syndromes in childhood: An analysis of 340 cases
62. Trabeculodialysis for inflammatory glaucoma in children and young adults
63. Glaucoma due to intraocular inflammation
64. Glaucoma in Fuchs' heterochromic uveitis: Etiology, management and outcome
65. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis
66. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma
67. Trabeculectomy with mitomycin C in glaucoma associated with uveitis
68. Trabeculectomy with mitomycin C for glaucoma associated with uveitis
69. The essential iris atrophies
70. Surgical results in iridocorneal endothelial syndrome
71. Glaucoma and the iridocorneal endothelial syndrome
72. Clinicopathologic correlation in Cogan-Reese syndrome
73. 5-Fluorouracil after trabeculectomy and the iridocorneal endothelial syndrome
74. Increased interleukin-6 in aqueous humor of neovascular glaucoma
75. Effect of TNF, IL-1, and IL-6 on the proliferation of human Tenon's capsule fibroblasts in tissue culture
76. The importance of cellular changes in the conjunctiva of patients with uveitic glaucoma undergoing trabeculectomy
77. The role of cytokines in chronic progressive conjunctival cicatrisation
78. Cicatricial pemphigoid
79. Glaucoma in blacks
80. Histologic differences in the conjunctiva of black and white glaucoma patients
81. The architecture of black and white facial skin
82. Structure and function of the skin: Are there differences between black and white skin?
83. Keloids
84. Cutaneous reaction patterns in blacks
85. Contact dermatitis in blacks
86. Black and white human skin differences
87. In vivo biophysical characterization of skin physiological differences in races
88. The architecture of black and white facial skin
89. Mast cell heterogeneity
90. Mast cell biology
91. Mast cell heparin stimulates migration of capillary endothelial cells in vitro
92. Mast cells and their mediators in cutaneous wound healing- active participants or innocent bystanders?
93. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound
94. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis
95. Chronic simple glaucoma in the negro
96. Glaucoma surgery in Nigerian eyes: A five-year study
97. Excision of Tenon's capsule in fistulizing operations on Africans
98. Failure of filtration operations in the African
99. Trabeculectomy with fistula formation in the African
100. Trabeculectomy and modifications of trabeculectomy
101. Use of a thin conjunctival flap in limbosclerectomy
102. Trabeculectomy, or trabeculectomy plus tenectomy: A comparative study
103. Mechanism of filtration of fistulizing glaucoma procedures
104. Some problems in the diagnosis and treatment of glaucoma
105. A possible etiology for glaucoma in Negroes
106. Na+-H+ antiport activity in skin fibroblasts from blacks and whites
107. Differences of Ca2+ regulation in skin fibroblasts from blacks and whites
108. A higher cellular sodium turnover rate in cultured skin flbroblasts from blacks
109. Cutaneous reactive hyperaemia: Racial differences induced by corticoid application
110. Biochemical abnormalities in the aqueous in chronic open-angle glaucoma
111. Adverse effects of topical anti-glaucomatous medications on the conjunctiva
112. The effect of topical anti-glaucomatous medications on the cell profile of the conjunctiva
113. Topical anti-glaucomatous therapy: Adverse effects on the conjunctiva and implications for filtration surgery
114. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucoma patients
115. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile
116. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: An immunohistochemical and ultrastructural study
117. The effects of antiglaucomatous agents on conjunctiva used for various durations
118. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal response
119. Effects of antiglaucoma drugs on ocular surface
120. Immunopathologic findings in conjunctival cells using immunofluorescence staining of impression cytology specimens
121. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma
122. Side effects of antiglaucomatous drugs on the ocular surface
123. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders
124. Effects of timolol, betaxolol and levobunolol on human Tenon's fibroblasts in tissue culture
125. The effect of topical beta-blocker medications on the proliferation and viability of human Tenon's capsule fibroblasts in tissue culture
126. Pilot study on the effect of topical adrenergic medications on human Tenon's capsule fibroblasts in tissue culture
127. Effects of topical glaucoma drugs on fistulized rabbit conjunctiva
128. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva
129. Histopathologic effects of topical ophthalmic preservatives on rat corneoconjunctival surface
130. Cytotoxicity of preservatives on cultured human conjunctival cells
131. Quantitative cytotoxicity of preservatives evaluated in cell culture with Chang's human conjunctival cells - Effect of temperature on cytotoxicity
132. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells
133. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: Human and animal studies
134. Mechanisms of failure in glaucoma filtering surgery: A consequence of antiglaucomatous drugs?
135. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers
136. Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension
137. Topical timolol with and without benzalkonium chloride: Epithelial permeability and autofluorescence of the cornea in glaucoma
138. Reversal of topical antiglaucoma medication effects on the conjunctiva
139. Filtering surgery in children: Barrier to success
140. Filtering surgery in childhood glaucoma
141. A critical analysis of the long-term results of trabeculectomy
142. Long-term evaluation of initial filtration surgery
143. The influence of age on the cell profile of the conjunctiva and the results of trabeculectomy
144. Morphological changes in the human conjunctival epithelium. I. In the normal elderly population
145. The conjunctiva
146. On the conjunctival papillae and follicles
147. Mucous gland system of the conjunctiva
148. Histologische untersuchungen zur becherzellzahl der menschlichen bindehaut
149. Primary trabeculectomy in young adults
150. Conjunctiva
151. Trabeculectomy with cautery
152. A method for studying collagen biosynthesis in human skin biopsies in vitro
153. The microvascular system of healing wounds in young and old rats
154. Aging of connective tissue: Physical properties of healing wounds in young and old rats
155. Transforming growth factor-beta in human aqueous humor
156. Immunolocalization of TGF-beta 1, TGF-beta 2 and TGF-beta 3 in the anterior segment of the human eye
157. Some recent advances in the chemistry and biology of transforming growth factor-beta
158. Transforming growth factor beta in tissue fibrosis
159. The effect of TGF-beta 1 and TGF-beta 2 on the proliferation of human Tenon's capsule fibroblasts in tissue culture
160. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents
161. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring
162. Human anti-transforming growth factor-beta 2 antibody: A new glaucoma anti-scarring agent
163. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2
164. Comparison of aqueous humor TGF-beta from cataract and glaucoma patients
165. TGF-beta 2 concentration in the aqueous humor of patients with glaucoma and cataracts